CDC6 and lung adenocarcinoma: Importantly, four of the top ten pathways (pathways with ranks 1, 2, 6 and 10) are associated with genes identified as either therapeutic targets for lung adenocarcinoma (Ran [34] and ATR [35, 36]) or as biomarkers of patient prognonsis (CDC6 [37]).